Home/Filings/4/0001415889-24-001543
4//SEC Filing

Perlich Irene 4

Accession 0001415889-24-001543

CIK 0001426332other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:02 PM ET

Size

4.9 KB

Accession

0001415889-24-001543

Insider Transaction Report

Form 4
Period: 2024-01-16
Perlich Irene
Principal Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2024-01-16$1.34/sh1,025$1,3748,975 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001989954

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:02 PM ET
Size
4.9 KB